SCHEMBL4304850

SCHEMBL4304850

N=C=NN1CCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6683833 0.80
SCHEMBL9526148 0.74
SCHEMBL28152272 0.74
SCHEMBL28804046 0.72
Hydrochloric Acid SCHEMBL31138322 0.70
SCHEMBL12311392 0.69
SCHEMBL3281225 0.64 USP2 (0.37)
SCHEMBL11633088 0.63
N-Nitrosomorpholine SCHEMBL1578515 0.63
SCHEMBL2571412 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100338030-C Method for purifying alficetin and its special immune affinity chromatographic column UNIV CHINA AGRICULTURAL (CN) 2007-09-19 CN claimed
CN-1807402-A Method for purifying alficetin and its special immune affinity chromatographic column UNIV CHINA AGRICULTURAL (CN) 2006-07-26 CN claimed
CN-104689340-A Tumor drug targeting vector and application LANZHOU VETERINARY RES INST CAAS 2015-06-10 CN disclosed
US-7550469-B2 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands AVENTIS PHARMACEUTICALS INC. (US) 2009-06-23 US disclosed
CN-100338030-C Method for purifying alficetin and its special immune affinity chromatographic column UNIV CHINA AGRICULTURAL (CN) 2007-09-19 CN disclosed
CN-100338030-C Method for purifying alficetin and its special immune affinity chromatographic column UNIV CHINA AGRICULTURAL (CN) 2007-09-19 CN disclosed
US-20070142351-A1 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands AVENTIS PHARMACEUTICALS INC. (US) 2007-06-21 US disclosed
EP-1688412-A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands Aventis Pharmaceuticals, Inc. (US) 2006-08-09 EP disclosed
CN-1807402-A Method for purifying alficetin and its special immune affinity chromatographic column UNIV CHINA AGRICULTURAL (CN) 2006-07-26 CN disclosed
CN-1807402-A Method for purifying alficetin and its special immune affinity chromatographic column UNIV CHINA AGRICULTURAL (CN) 2006-07-26 CN disclosed
US-20050107389-A1 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands AVENTIS PHARMACEUTICALS INC. (US) 2005-05-19 US disclosed
US-20040030137-A1 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-02-12 US disclosed
EP-1361875-A2 NOVEL HETEROCYCLIC AMIDE DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS Aventis Pharmaceuticals Inc. (US) 2003-11-19 EP disclosed
WO-2002066469-A2 NOVEL HETEROCYCLIC AMIDE DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS AVENTIS PHARMACEUTICALS INC. (US) 2002-08-29 WO disclosed
WO-1994023102-A1 METHOD FOR THE PRODUCTION OF AN ENZYMATIC SENSOR AND PRODUCT OBTAINED ECOLE CENTRALE DE LYON (FR) 1994-10-13 WO disclosed
US-4690908-A Measuring reagent kit for determining an antigen, antibody or antigen-antibody complex MOCHIDA SEIYAKU KABUSHIKI KAISHA (JP) 1987-09-01 US disclosed
US-4332788-A SPECTROPHOTOMETRIC MOCHIDA SEIYAKU KABUSHIKI KAISHA (JP) 1982-06-01 US disclosed